-
1
-
-
79961108629
-
Reduced lung-cancer mortality with low-dose computed tomographic screening
-
National Lung Screening Trial Research Team
-
National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 2011; 365: 395-409.
-
(2011)
N. Engl. J. Med.
, vol.365
, pp. 395-409
-
-
Aberle, D.R.1
Adams, A.M.2
Berg, C.D.3
Black, W.C.4
Clapp, J.D.5
Fagerstrom, R.M.6
Gareen, I.F.7
Gatsonis, C.8
Marcus, P.M.9
-
2
-
-
84883374872
-
Results of the two incidence screenings in the National Lung Screening Trial
-
Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, et al. Results of the two incidence screenings in the National Lung Screening Trial. N. Engl. J. Med. 2013; 369: 920-931.
-
(2013)
N. Engl. J. Med.
, vol.369
, pp. 920-931
-
-
Aberle, D.R.1
Demello, S.2
Berg, C.D.3
Black, W.C.4
Brewer, B.5
Church, T.R.6
Clingan, K.L.7
Duan, F.8
Fagerstrom, R.M.9
Gareen, I.F.10
-
3
-
-
77953930730
-
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR
-
Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N. Engl. J. Med. 2010; 362: 2380-2388.
-
(2010)
N. Engl. J. Med.
, vol.362
, pp. 2380-2388
-
-
Maemondo, M.1
Inoue, A.2
Kobayashi, K.3
Sugawara, S.4
Oizumi, S.5
Isobe, H.6
Gemma, A.7
Harada, M.8
Yoshizawa, H.9
Kinoshita, I.10
-
4
-
-
80155150303
-
Personalized medicine in lung cancer: What we need to know
-
Mok TS,. Personalized medicine in lung cancer: what we need to know. Nat. Rev. Clin. Oncol. 2011; 8: 661-668.
-
(2011)
Nat. Rev. Clin. Oncol.
, vol.8
, pp. 661-668
-
-
Mok, T.S.1
-
5
-
-
34547638047
-
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
-
Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448: 561-566.
-
(2007)
Nature
, vol.448
, pp. 561-566
-
-
Soda, M.1
Choi, Y.L.2
Enomoto, M.3
Takada, S.4
Yamashita, Y.5
Ishikawa, S.6
Fujiwara, S.7
Watanabe, H.8
Kurashina, K.9
Hatanaka, H.10
-
6
-
-
79954606778
-
Targeting anaplastic lymphoma kinase in lung cancer
-
Shaw AT, Solomon B,. Targeting anaplastic lymphoma kinase in lung cancer. Clin. Cancer Res. 2011; 17: 2081-2086.
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 2081-2086
-
-
Shaw, A.T.1
Solomon, B.2
-
7
-
-
84861976984
-
Whole genome sequencing for lung cancer
-
Daniels M, Goh F, Wright CM, Sriram KB, Relan V, Clarke BE, Duhig EE, Bowman RV, Yang IA, Fong KM,. Whole genome sequencing for lung cancer. J. Thorac. Dis. 2012; 4: 155-163.
-
(2012)
J. Thorac. Dis.
, vol.4
, pp. 155-163
-
-
Daniels, M.1
Goh, F.2
Wright, C.M.3
Sriram, K.B.4
Relan, V.5
Clarke, B.E.6
Duhig, E.E.7
Bowman, R.V.8
Yang, I.A.9
Fong, K.M.10
-
8
-
-
84903556056
-
An emerging place for lung cancer genomics in 2013
-
Daniels MG, Bowman RV, Yang IA, Govindan R, Fong KM,. An emerging place for lung cancer genomics in 2013. J. Thorac. Dis. 2013; 5: S491-497.
-
(2013)
J. Thorac. Dis.
, vol.5
, pp. S491-S497
-
-
Daniels, M.G.1
Bowman, R.V.2
Yang, I.A.3
Govindan, R.4
Fong, K.M.5
|